Literature DB >> 33777278

Chronic Hepatitis C Virus Infection Modulates the Transcriptional Profiles of CD4+ T Cells.

Michal Holub1, Alžběta Stráníková1, Ondřej Beran1, Simona Arientová1, Oldřich Bartoš1,2, Kateřina Kondelková3, Stanislav Plíšek4, Pavel Chalupa5.   

Abstract

BACKGROUND: Chronic hepatitis C (CHC) is associated with altered cell-mediated immune response.
OBJECTIVE: The aim of the study was to characterize functional alterations in CD4+ T cell subsets and myeloid-derived suppressor cells (MDSCs) during chronic hepatitis C virus (HCV) infection. Methodology. The expression levels of the lineage-defining transcriptional factors (TFs) T-bet, Gata3, Rorγt, and Foxp3 in circulating CD4+ T cells and percentages of MDSCs in peripheral blood were evaluated in 33 patients with CHC, 31 persons, who had spontaneously cleared the HCV infection, and 30 healthy subjects. Analysis. The CD4+ T cells TFs T-bet (T-box expressed in T cells), Foxp3 (Forkhead box P3 transcription factor), Gata3 (Gata-binding protein 3), and Rorγt (retinoic-acid-related orphan receptor gamma) and activation of CD8+ T cells, as well as percentages of MDSCs, were measured by multicolor flow cytometry after intracellular and surface staining of peripheral blood mononuclear cells with fluorescent monoclonal antibodies. RESULT: The patients with CHC had significantly lower percentages of CD4+ T cells expressing Rorγt and Gata3 and higher percentages of Foxp3-expressing CD4+ T cells than healthy controls and persons who spontaneously cleared HCV infection. The ratios of T-bet+/Gata3+ and Foxp3+/Rorγt+ CD4+ T cells were the highest in the patients with CHC. In the patients with CHC, the percentages of Gata3+ and Rorγt+ CD4+ T cells and the percentages of T-bet+ CD4+ T cells and CD38+/HLA-DR+ CD8+ T cells demonstrated significant positive correlations. In addition, the percentage of CD38+/HLA-DR+ CD8+ T cells correlated negatively with the percentage of MDSCs.
CONCLUSION: Chronic HCV infection is associated with downregulation of TFs Gata3 and Rorγt polarizing CD4+ T cells into Th2 and Th17 phenotypes together with upregulation of Foxp3 responsible for induction of regulatory T cells suppressing immune response.
Copyright © 2021 Michal Holub et al.

Entities:  

Year:  2021        PMID: 33777278      PMCID: PMC7979312          DOI: 10.1155/2021/6689834

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  24 in total

1.  Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.

Authors:  Dongping Xu; Junliang Fu; Lei Jin; Hui Zhang; Chunbao Zhou; Zhengsheng Zou; Jing-Min Zhao; Bin Zhang; Ming Shi; Xilai Ding; Zirong Tang; Yang-Xin Fu; Fu-Sheng Wang
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 2.  Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells.

Authors:  John J O'Shea; William E Paul
Journal:  Science       Date:  2010-02-26       Impact factor: 47.728

3.  Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta.

Authors:  Pavel Chalupa; Alžběta Davidová; Ondřej Beran; Simona Arientová; Pavel Boštík; Jaroslav Kapla; Kateřina Kondělková; Stanislav Plíšek; Michal Holub
Journal:  APMIS       Date:  2016-06-16       Impact factor: 3.205

Review 4.  Th17 and IL-17 immunity in chronic hepatitis C infection.

Authors:  P Bălănescu; Anca Lădaru; T Voiosu; Adriana Nicolau; Mihaela Ene; Eugenia Bălănescu
Journal:  Rom J Intern Med       Date:  2012 Jan-Mar

5.  Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries.

Authors:  Hakan Leblebicioglu; Joop E Arends; Resat Ozaras; Giampaolo Corti; Lurdes Santos; Christoph Boesecke; Andrew Ustianowski; Ann-Sofi Duberg; Simona Ruta; Nermin N Salkic; Petr Husa; Ivana Lazarevic; Juan A Pineda; Natalia Yurievna Pshenichnaya; Tengiz Tsertswadze; Mojca Matičič; Edmond Puca; Gulzhan Abuova; Judit Gervain; Ramin Bayramli; Salih Ahmeti; Mairi Koulentaki; Badreddine Kilani; Adriana Vince; Francesco Negro; Mustafa Sunbul; Dominique Salmon
Journal:  Antiviral Res       Date:  2017-12-05       Impact factor: 5.970

6.  HCV infection enhances Th17 commitment, which could affect the pathogenesis of autoimmune diseases.

Authors:  Yasuteru Kondo; Masashi Ninomiya; Osamu Kimura; Keigo Machida; Ryo Funayama; Takeshi Nagashima; Koju Kobayashi; Eiji Kakazu; Takanobu Kato; Keiko Nakayama; Michael M C Lai; Tooru Shimosegawa
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  Polymorphisms in the Th17 cell-related RORC gene are associated with spontaneous clearance of HCV in Chinese women.

Authors:  Zhe Xie; Yuantao Li; Lu Long; Hua Liang; Weiping Cai; Tao Shen
Journal:  BMC Infect Dis       Date:  2018-06-04       Impact factor: 3.090

Review 8.  Hepatitis C Virus Infection: Host⁻Virus Interaction and Mechanisms of Viral Persistence.

Authors:  DeGaulle I Chigbu; Ronak Loonawat; Mohit Sehgal; Dip Patel; Pooja Jain
Journal:  Cells       Date:  2019-04-25       Impact factor: 6.600

9.  Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.

Authors:  Hassen Kared; Thomas Fabre; Nathalie Bédard; Julie Bruneau; Naglaa H Shoukry
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

10.  T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription.

Authors:  Takashi Usui; Jan C Preiss; Yuka Kanno; Zheng Ju Yao; Jay H Bream; John J O'Shea; Warren Strober
Journal:  J Exp Med       Date:  2006-03-06       Impact factor: 14.307

View more
  1 in total

Review 1.  Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection.

Authors:  Mehlayl Tariq; Abu Bakar Shoukat; Sedrah Akbar; Samaia Hameed; Muniba Zainab Naqvi; Ayesha Azher; Muhammad Saad; Muhammad Rizwan; Muhammad Nadeem; Anum Javed; Asad Ali; Shahid Aziz
Journal:  SAGE Open Med       Date:  2022-06-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.